Article
Clinical Implications of the Autophagy Core Gene Variations in Advanced Lung Adenocarcinoma Treated with Gefitinib.
Scientific reports - 19 Dec 2017
Yuan Jupeng, Zhang Nasha, Yin Longbin, Zhu Hui, Zhang Li, Zhou Liqing, Yang Ming
Abstract excerpt
EGFR-TKIs show dramatic treatment benefits for advanced lung adenocarcinoma patients with activating EGFR mutations. Considering the essential role of autophagy in EGFR-TKIs treatments, we hypothesized that genetic variants in autophagy core genes might contribute to outcomes of advanced lung adenocarcinoma treated with gefitinib. We systematically examined 27 potentially functional genetic polymorphisms in 11...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
